CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 161 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,535,021 | -35.0% | 164,790 | -19.8% | 0.03% | -30.8% |
| Q2 2023 | $6,972,886 | +33.0% | 205,508 | +41.0% | 0.04% | +8.3% |
| Q1 2023 | $5,243,581 | -17.9% | 145,736 | +1.7% | 0.04% | -32.1% |
| Q4 2022 | $6,388,263 | +9.4% | 143,331 | -31.0% | 0.05% | -14.5% |
| Q3 2022 | $5,838,000 | +74.9% | 207,693 | +67.8% | 0.06% | +100.0% |
| Q2 2022 | $3,338,000 | -37.3% | 123,806 | -20.8% | 0.03% | -3.1% |
| Q1 2022 | $5,322,000 | -4.4% | 156,252 | +8.4% | 0.03% | +10.3% |
| Q4 2021 | $5,569,000 | +80.5% | 144,115 | +152.2% | 0.03% | +38.1% |
| Q3 2021 | $3,085,000 | +17.5% | 57,144 | -27.2% | 0.02% | +23.5% |
| Q2 2021 | $2,625,000 | +5.3% | 78,501 | -35.2% | 0.02% | 0.0% |
| Q1 2021 | $2,494,000 | +451.8% | 121,059 | +369.4% | 0.02% | +325.0% |
| Q4 2020 | $452,000 | – | 25,791 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|